Skip to main content

Johnson & Johnson

corporate_fare Company Profile

Johnson & Johnson

JNJ·NYSE·Life Sciences·CIK 0000200406

Johnson & Johnson is a global healthcare company with approximately 138,200 employees worldwide. The company focuses on the research, development, manufacturing, and sale of a wide range of products primarily related to human health and well-being. Incorporated in New Jersey in 1887, Johnson & Johnson operates through its subsidiaries in virtually all countries globally. The company is structured into two main business segments: Innovative Medicine and MedTech. The Innovative Medicine segment concentrates on several therapeutic areas. These include Oncology, addressing conditions such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer. In Immunology, the focus is on rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis. Neuroscience covers mood disorders, neurodegenerative disorders, and schizophrenia. The segment also addresses Pulmonary Hypertension, specifically Pulmonary Arterial Hypertension, and Infectious Diseases like HIV/AIDS. Additionally, it covers Cardiovascular and Metabolism, including thrombosis, diabetes, and macular degeneration. Products within the Innovative Medicine segment are distributed for prescription use directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals.

Johnson & Johnson (NYSE:JNJ) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 66 items for JNJ at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • CEO Joaquin Duato Files to Sell $32.2M in J&J Shares
  • J&J CEO Joaquin Duato Files to Sell $12.4M in Stock
  • FDA Grants Priority Review to J&J's Rybrevant Faspro for Head and Neck Cancer
  • J&J Slashes 2026 Profit Outlook by $0.64 on Deal Costs, Warns of Bigger 2027 Hit
  • J&J Acquires Firefly Bio to Boost Next-Gen Oncology Pipeline

Financial Snapshot

Fiscal year ended December 28, 2025
Revenue
$94.19B
Net Income
$26.8B
Diluted EPS
$11.03
Op. Cash Flow
$24.53B
Free Cash Flow
$19.7B
Gross Profit
$63.94B
Cash & Equivalents
$19.71B
Total Debt
$41.44B
Debt / Equity
0.51×
Net Margin
28.5%
Shares Outstanding
2.41B sh
Source: 10-K · filed 2026-02-11 · accession 0000200406-26-000016
$271.06 +0.87% today
52-week range · as of 2026-10-21 $184.66 – $281.07
Market cap
$652.53B
Volume
3M (0.4× avg)
3-mo avg 7.4M
Live data · 2026-10-28 17:50 UTC · Market open

show_chartPrice Chart

Loading chart...

feed JNJ - Filings & News (Page 2)

JNJ
Aug 13, 2026, 2:12 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $261.49
Real-time Price: $271.06 info
Change: +$9.57 (+4%) info
Market Cap: $652.535B info
JNJ
Aug 05, 2026, 6:07 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $258.24
Real-time Price: $271.06 info
Change: +$12.83 (+5%) info
Market Cap: $652.535B info
JNJ
Jul 30, 2026, 8:41 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $260.52
Real-time Price: $271.06 info
Change: +$10.54 (+4%) info
Market Cap: $652.535B info
JNJ
Jul 29, 2026, 5:53 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $261.39
Real-time Price: $271.06 info
Change: +$9.67 (+4%) info
Market Cap: $652.535B info
JNJ
Jul 29, 2026, 5:42 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $262.50
Real-time Price: $271.06 info
Change: +$8.56 (+3%) info
Market Cap: $652.535B info
JNJ
Jul 29, 2026, 5:28 PM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $265.65
Real-time Price: $271.06 info
Change: +$5.41 (+2%) info
Market Cap: $652.535B info
JNJ
Jul 29, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $261.96
Real-time Price: $271.06 info
Change: +$9.10 (+3%) info
Market Cap: $652.535B info
JNJ
Jul 27, 2026, 6:32 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $280.00
Real-time Price: $271.06 info
Change: -$8.94 (-3%) info
Market Cap: $652.535B info
JNJ
Jul 24, 2026, 7:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $259.50
Real-time Price: $271.06 info
Change: +$11.56 (+4%) info
Market Cap: $652.535B info
JNJ
Jul 23, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $259.00
Real-time Price: $271.06 info
Change: +$12.06 (+5%) info
Market Cap: $652.535B info
JNJ
Jul 23, 2026, 9:43 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $257.44
Real-time Price: $271.06 info
Change: +$13.62 (+5%) info
Market Cap: $652.535B info
JNJ
Jul 22, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $252.22
Real-time Price: $271.06 info
Change: +$18.85 (+7%) info
Market Cap: $652.535B info
JNJ
Jul 16, 2026, 8:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $249.00
Real-time Price: $271.06 info
Change: +$22.06 (+9%) info
Market Cap: $652.535B info
JNJ
Jul 16, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $247.37
Real-time Price: $271.06 info
Change: +$23.69 (+10%) info
Market Cap: $652.535B info
JNJ
Jul 15, 2026, 11:14 AM EDT
Source: ShareCast
Importance Score:
8
Price at Filing: $253.48
Real-time Price: $271.06 info
Change: +$17.58 (+7%) info
Market Cap: $652.535B info
JNJ
Jul 15, 2026, 7:49 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $248.86
Real-time Price: $271.06 info
Change: +$22.20 (+9%) info
Market Cap: $652.535B info
JNJ
Jul 15, 2026, 6:20 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $257.50
Real-time Price: $271.06 info
Change: +$13.56 (+5%) info
Market Cap: $652.535B info
JNJ
Jun 23, 2026, 2:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $237.72
Real-time Price: $271.06 info
Change: +$33.34 (+14%) info
Market Cap: $652.535B info
JNJ
Jun 15, 2026, 6:29 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $239.00
Real-time Price: $271.06 info
Change: +$32.06 (+13%) info
Market Cap: $652.535B info
JNJ
Jun 13, 2026, 6:39 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $240.01
Real-time Price: $271.06 info
Change: +$31.05 (+13%) info
Market Cap: $652.535B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets